<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Vet Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">J. Vet. Intern. Med</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1939-1676</journal-id><journal-id journal-id-type="publisher-id">JVIM</journal-id><journal-title-group><journal-title>Journal of Veterinary Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">0891-6640</issn><issn pub-type="epub">1939-1676</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24697827</article-id><article-id pub-id-type="pmc">4895464</article-id><article-id pub-id-type="doi">10.1111/jvim.12352</article-id><article-id pub-id-type="publisher-id">JVIM12352</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Standard Articles</subject></subj-group></article-categories><title-group><article-title>A Randomized Study Assessing the Effect of Diet in Cats with Hypertrophic Cardiomyopathy</article-title><alt-title alt-title-type="left-running-head">Freeman et&#x000a0;al</alt-title></title-group><contrib-group><contrib id="jvim12352-cr-0001" contrib-type="author" corresp="yes"><name><surname>Freeman</surname><given-names>L.M.</given-names></name><xref ref-type="aff" rid="jvim12352-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12352-cr-0002" contrib-type="author"><name><surname>Rush</surname><given-names>J.E.</given-names></name><xref ref-type="aff" rid="jvim12352-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12352-cr-0003" contrib-type="author"><name><surname>Cunningham</surname><given-names>S.M.</given-names></name><xref ref-type="aff" rid="jvim12352-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jvim12352-cr-0004" contrib-type="author"><name><surname>Bulmer</surname><given-names>B.J.</given-names></name><xref ref-type="aff" rid="jvim12352-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="jvim12352-curr-0001">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="jvim12352-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Clinical Sciences</named-content><institution>Tufts Cummings School of Veterinary Medicine</institution><named-content content-type="city">North Grafton</named-content><named-content content-type="country-part">MA</named-content></aff><aff id="jvim12352-curr-0001"><label><sup>2</sup></label>Present address: <institution>Tufts Veterinary Emergency Treatment &#x00026; Specialties</institution><named-content content-type="street">525 South Street</named-content><named-content content-type="city">Walpole</named-content><named-content content-type="country-part">MA</named-content><named-content content-type="post-code">02081</named-content></aff><author-notes><corresp id="correspondenceTo"><label>*</label><italic>Corresponding author: L.M. Freeman, Tufts Cummings School of Veterinary Medicine, Department of Clinical Sciences, 200 Westboro Road, North Grafton, MA 01536;</italic> e&#x02010;mail: <email>lisa.freeman@tufts.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>4</month><year>2014</year></pub-date><pub-date pub-type="ppub"><season>May-Jun</season><year>2014</year></pub-date><volume>28</volume><issue>3</issue><issue-id pub-id-type="doi">10.1111/jvim.2014.28.issue-3</issue-id><fpage>847</fpage><lpage>856</lpage><history><date date-type="received"><day>20</day><month>8</month><year>2013</year></date><date date-type="rev-recd"><day>20</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>24</day><month>2</month><year>2014</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2014 American College of Veterinary Internal Medicine <copyright-statement>--><copyright-statement content-type="article-copyright">Copyright &#x000a9; 2014 by the American College of Veterinary Internal Medicine</copyright-statement></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JVIM-28-0847.pdf"/><abstract id="jvim12352-abs-0001"><sec id="jvim12352-sec-0001"><title>Background</title><p>Diet might influence progression of hypertrophic cardiomyopathy (<styled-content style="fixed-case">HCM</styled-content>).</p></sec><sec id="jvim12352-sec-0002"><title>Objective</title><p>To investigate whether diet composition could alter clinical, biochemical, or echocardiographic variables in cats with <styled-content style="fixed-case">HCM</styled-content>.</p></sec><sec id="jvim12352-sec-0003"><title>Animals</title><p>Twenty&#x02010;nine cats with <styled-content style="fixed-case">HCM</styled-content> (International Small Animal Cardiac Health Council stage 1b) examined at a university teaching hospital.</p></sec><sec id="jvim12352-sec-0004"><title>Methods</title><p>Randomized, placebo&#x02010;controlled trial. After physical examination, echocardiogram, and blood collection, cats were randomized to 1 of 3 diets, which varied in carbohydrate and fat content and ingredients. Measurements were repeated after 6&#x000a0;months.</p></sec><sec id="jvim12352-sec-0005"><title>Results</title><p>There were no significant differences among the 3 groups at baseline. After 6&#x000a0;months, there were no significant changes in the primary endpoints, left ventricular free wall (Group A, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.760; Group B, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.475; Group C, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.066) or interventricular septal thickness in diastole (Group A, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.528; Group B, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.221; Group C, <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.097). Group A had significant increases in <styled-content style="fixed-case">BUN</styled-content> (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.008) and cholesterol (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.021), while Group B had significant increases in <styled-content style="fixed-case">BUN</styled-content> (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.008), cholesterol (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.007), and triglycerides (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.005), and significant decreases in <styled-content style="fixed-case">NT</styled-content>&#x02010;pro<styled-content style="fixed-case">BNP</styled-content> (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.013) and hs&#x02010;troponin I (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.043). Group C had significant decreases in body weight (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.021), left atrial dimension (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.035), interventricular septal thickness in systole (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.038), and liver enzymes (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.034&#x02013;.038).</p></sec><sec id="jvim12352-sec-0006"><title>Conclusions and Clinical Importance</title><p>These data suggest that diet might influence some clinical, biochemical, and echocardiographic variables in cats with <styled-content style="fixed-case">HCM</styled-content>.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jvim12352-kwd-0001">Cardiomyopathy</kwd><kwd id="jvim12352-kwd-0002">Congestive heart failure</kwd><kwd id="jvim12352-kwd-0003">Nutrition</kwd></kwd-group><funding-group><award-group><funding-source>Barkley Fund</funding-source></award-group></funding-group><counts><page-count count="10"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jvim12352</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May/June 2014</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.9 mode:remove_FC converted:06.05.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jvim12352-ntgp-0001"><fn id="jvim12352-note-0001"><p>Presented, in part, at the 2013 ACVIM Forum, Seattle, WA</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="jvim12352-dl-0001"><title>Abbreviations</title><def-item><term>2D</term><def><p>2&#x02010;dimensional</p></def></def-item><def-item><term>A'</term><def><p>late diastolic myocardial velocity</p></def></def-item><def-item><term>A</term><def><p>late diastolic velocity of mitral inflow</p></def></def-item><def-item><term>ALP</term><def><p>alkaline phosphatase</p></def></def-item><def-item><term>ALT</term><def><p>alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p>aspartate aminotransferase</p></def></def-item><def-item><term>BCS</term><def><p>body condition score</p></def></def-item><def-item><term>CHF</term><def><p>congestive heart failure</p></def></def-item><def-item><term>DHA</term><def><p>docosahexaenoic acid</p></def></def-item><def-item><term>E'</term><def><p>early peak diastolic myocardial velocity</p></def></def-item><def-item><term>E</term><def><p>early diastolic velocity of mitral inflow</p></def></def-item><def-item><term>EPA</term><def><p>eicosapentaenoic acid</p></def></def-item><def-item><term>HCM</term><def><p>hypertrophic cardiomyopathy</p></def></def-item><def-item><term>HOMA</term><def><p>homeostasis model assessment</p></def></def-item><def-item><term>hs&#x02010;troponin I</term><def><p>high&#x02010;sensitivity cardiac troponin I</p></def></def-item><def-item><term>ISACHC</term><def><p>International Small Animal Cardiac Health Council</p></def></def-item><def-item><term>IVRT</term><def><p>isovolumic relaxation time</p></def></def-item><def-item><term>IVSd/s</term><def><p>interventricular septal thickness in diastole/systole</p></def></def-item><def-item><term>LA</term><def><p>left atrium</p></def></def-item><def-item><term>LVIDd/s</term><def><p>left ventricular internal dimension in diastole/systole</p></def></def-item><def-item><term>LVWd/s</term><def><p>left ventricular free wall thickness in diastole/systole</p></def></def-item><def-item><term>NT&#x02010;proBNP</term><def><p>N&#x02010;terminal pro B&#x02010;type natriuretic peptide</p></def></def-item></def-list><p>Gene&#x02013;nutrient interactions might play a role in the wide phenotypic variation seen in hypertrophic cardiomyopathy (HCM) in both people and cats. This area of research is relatively new, but there is some evidence suggesting that diet or nutrients can modify phenotypic expression of cardiomyopathy in genetically predisposed individuals. In 1 study,<xref rid="jvim12352-bib-0001" ref-type="ref">1</xref> mice with an alpha&#x02010;myosin heavy chain mutation were fed either a soy&#x02010; or casein&#x02010;based diet, and the results showed that males eating the soy&#x02010;based diet developed more severe heart disease compared with those eating the casein&#x02010;based diet. Another study in spontaneously hypertensive heart failure (SHHF) rats<xref rid="jvim12352-bib-0002" ref-type="ref">2</xref> showed that rats fed a test diet (higher in carbohydrate and sucrose and lower in protein) developed higher blood pressure, glucose, inflammatory mediators, and left ventricular free wall in diastole (LVWd), and also an accelerated development of congestive heart failure (CHF) and death compared with rats eating the control diet. Finally, in a recent study of 275 adult people with HCM, not only was left ventricular mass higher in overweight and obese patients but obesity also was an independent predictor of progression to New York Heart Association Class III or IV.<xref rid="jvim12352-bib-0003" ref-type="ref">3</xref> While the authors<xref rid="jvim12352-bib-0003" ref-type="ref">3</xref> and the corresponding editorial<xref rid="jvim12352-bib-0004" ref-type="ref">4</xref> attributed obesity to being a secondary effect of HCM (ie, because people with HCM are less likely to be physically active, they are more likely to become obese), it is possible that the obesity contributed to a worse phenotypic expression of the disease and that this hastened disease progression.</p><p>The relationship between dietary factors and cardiovascular phenotype in cats with HCM has not been reported. However, there currently is a large variety of commercial cat foods available from which consumers can choose. These diets vary in ingredients and nutrient profiles, including macronutrients (ie, protein, fat, carbohydrate), micronutrients (eg, essential vitamins and minerals), and other nutrients that also can have nonnutritional effects (eg, omega&#x02010;3 fatty acids, antioxidants). It is not yet known whether this wide spectrum of dietary properties found in commercial cat foods could alter phenotypic expression of disease in cats with HCM, but identifying methods for slowing progression of HCM would be useful. If modification of diet could be shown to alter progression of disease, time to CHF, survival time, or quality of life, this would be beneficial for the cats with this common disease.</p><p>To begin to investigate the role of diet in modifying disease, the objective of this randomized study was to investigate whether diet composition could alter clinical, biochemical, or echocardiographic variables in cats with HCM, but with no clinical signs.</p><sec id="jvim12352-sec-0008"><title>Materials and Methods</title><p>This randomized parallel&#x02010;design study was approved by the Tufts Cummings School of Veterinary Medicine Clinical Studies Review Committee. Cats with HCM were recruited from clients, staff, and students of Tufts Cummings School of Veterinary Medicine. All owners signed an informed consent form before enrolling cats in the study. To be eligible, cats had to have typical echocardiographic features of HCM (see below) and be without clinical signs for heart disease (International Small Animal Cardiac Health Council stage 1b).<xref rid="jvim12352-bib-0005" ref-type="ref">5</xref> Cats were excluded if they had important concurrent disease (eg, cancer, diabetes, chronic kidney disease) based on the history, physical examination, and laboratory testing. Physical examination was performed by a board&#x02010;certified cardiologist and all body condition scores (BCS) and muscle condition scores (MCS) were performed by a single investigator (LMF). Body condition scores were assessed using a 9&#x02010;point score,<xref rid="jvim12352-bib-0006" ref-type="ref">6</xref> while muscle condition was graded as normal, mild muscle loss, moderate muscle loss, or severe muscle loss.<xref rid="jvim12352-bib-0007" ref-type="ref">7</xref> Blood pressure was measured by Doppler technique using the mean of 3 systolic measurements. Cats with a mean systolic blood pressure &#x0003e;180&#x000a0;mmHg were considered hypertensive and excluded from the study. A diet history was collected from all cats' owners to determine the specific cat foods provided to the cat, as well as treats, table foods, dietary supplements, and foods used to administer medications. The amount of dry versus canned food was categorized as all dry, mostly dry, half dry and half canned (when approximately 50% of calories were provided by each form of food), mostly canned, and all canned. Dietary sodium content of the cats' usual diet was calculated using manufacturers' information on a mg/100&#x000a0;kcal basis.</p><p>Echocardiography (2D, M&#x02010;mode, and color flow, spectral and tissue Doppler)<xref ref-type="fn" rid="jvim12352-note-1001">1</xref> was performed on all cats. For echocardiography, right parasternal long&#x02010; and short&#x02010;axis views were obtained, and left apical 4&#x02010; and 5&#x02010;chamber views were also obtained. Left ventricular, left atrial, and aortic M&#x02010;mode dimensions were measured in right parasternal short&#x02010;axis views using 2D guidance.<xref rid="jvim12352-bib-0008" ref-type="ref">8</xref>, <xref rid="jvim12352-bib-0009" ref-type="ref">9</xref> The 2D left atrial and aortic dimensions were obtained in the right parasternal short&#x02010;axis view in diastole,<xref rid="jvim12352-bib-0010" ref-type="ref">10</xref> and the 2D interventricular septum and left ventricular free wall measurements were obtained in the right parasternal short&#x02010; or long&#x02010;axis view of the left ventricle in end&#x02010;diastole. Cats were diagnosed with HCM if they had either an interventricular septal thickness in diastole (IVSd) or LVWd &#x0003e;0.6&#x000a0;cm,<xref rid="jvim12352-bib-0011" ref-type="ref">11</xref> measured by 2D or M&#x02010;mode echocardiography and concurrent findings indicative of HCM (ie, some combination of systolic anterior motion of the mitral valve, left atrial enlargement, or increased aortic velocity). In cats in which the E and A waves were fused (n&#x000a0;=&#x000a0;2 at baseline and n&#x000a0;=&#x000a0;2 at follow&#x02010;up visits), values for those waves were not used. No medications were changed at the time of starting the study. If a medication change was judged by the cardiologist to be clinically necessary, that change was made and enrollment in the diet study was delayed for at least 8&#x000a0;weeks. In this situation, all baseline measurements (ie, physical examination, echocardiography, laboratory testing, blood pressure) were performed at the time of enrollment in the diet study.</p><p>Blood was collected by jugular venipuncture into serum (biochemistry profile, insulin, high&#x02010;sensitivity troponin I [hs&#x02010;troponin I], T4 if &#x0003e;6&#x000a0;years of age) and EDTA tubes (N&#x02010;terminal pro B&#x02010;type natriuretic peptide [NT&#x02010;proBNP]). The biochemistry profile (and T4, if performed) was analyzed immediately and the remaining tubes were centrifuged. Serum was frozen at &#x02212;80&#x000b0;C for batch analysis of insulin<xref ref-type="fn" rid="jvim12352-note-1002">2</xref> and hs&#x02010;troponin I.<xref ref-type="fn" rid="jvim12352-note-1003">3</xref> Plasma was transferred from the EDTA tube to a protease inhibitor tube, agitated gently, and then the plasma was frozen at &#x02212;80&#x000b0;C until analysis for NT&#x02010;proBNP was performed.<xref ref-type="fn" rid="jvim12352-note-1004">4</xref> The homeostasis model assessment (HOMA), a calculation that has been used as an estimate of insulin sensitivity in cats, was calculated using the formula: HOMA = [(insulin &#x000d7; glucose)/22.5].<xref rid="jvim12352-bib-0012" ref-type="ref">12</xref>
</p><p>After ensuring eligibility and baseline assessments, cats were randomized to 1 of 3 diet groups.<xref ref-type="fn" rid="jvim12352-note-1005">5</xref>, <xref ref-type="fn" rid="jvim12352-note-1006">6</xref>, <xref ref-type="fn" rid="jvim12352-note-1007">7</xref>, <xref ref-type="fn" rid="jvim12352-note-0008">8</xref>, <xref ref-type="fn" rid="jvim12352-note-0009">9</xref>, <xref ref-type="fn" rid="jvim12352-note-0010">10</xref> A random number table was developed by 1 investigator (LMF) using a computer&#x02010;based random number generator. As this was designed as a pilot study, controlled test diets were not formulated for the study, but instead, commercially available foods with the desired properties were selected with the goal of having all 3 diet groups mildly sodium&#x02010;restricted (&#x02264;100&#x000a0;mg/100&#x000a0;kcal), but to vary in carbohydrate, fat, and main ingredients (Table&#x000a0;<xref rid="jvim12352-tbl-0001" ref-type="table-wrap">1</xref>). For each group, commercially available dry and canned diets were selected that were similar to one another in nutrient profile and ingredients. Cardiologists and all students and other clinicians working with the cats were blinded to the random allocation sequence and diet assignment until the entire study had been completed. Only 1 investigator (LMF) and the owners were aware of the diet assignment and all communications with cat owners regarding diet were made with that 1 investigator to ensure that other clinicians remained blinded. After the initial visit, the owner was instructed to make a gradual change to the new diet over 4&#x02013;5&#x000a0;days and then to feed only the assigned study diet for the next 6&#x000a0;months. Owners were allowed to provide up to 5% of the cat's total daily calorie intake from low&#x02010;sodium treats or table food if this had been their usual practice before starting the study and if they kept this practice consistent throughout the study. Owners were instructed to feed an amount to maintain current body weight for the duration of the study. Owners were encouraged to weigh the cat during the study, especially if body weight appeared to be changing, so that adjustment of food amounts could be made. Owners were contacted monthly for progress reports and to ensure adequate food supply. After the study was underway, diets were analyzed for the isoflavones, genestein and daidzein, using HPLC with UV detection as previously described.<xref rid="jvim12352-bib-0013" ref-type="ref">13</xref>
</p><table-wrap id="jvim12352-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Nutritional profiles for the 3 diet groups. Each diet group had a canned and dry option.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1">Nutrient</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group A</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group B</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group C</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Dry<xref ref-type="fn" rid="jvim12352-note-1005">5</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Canned<xref ref-type="fn" rid="jvim12352-note-1006">6</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Dry<xref ref-type="fn" rid="jvim12352-note-1007">7</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Canned<xref ref-type="fn" rid="jvim12352-note-0008">8</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Dry<xref ref-type="fn" rid="jvim12352-note-0009">9</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">Canned<xref ref-type="fn" rid="jvim12352-note-0010">10</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ME (kcal/kg)<xref ref-type="fn" rid="jvim12352-note-0002">*</xref>
</td><td align="left" rowspan="1" colspan="1">3,942</td><td align="left" rowspan="1" colspan="1">952</td><td align="left" rowspan="1" colspan="1">3,960</td><td align="left" rowspan="1" colspan="1">1,001</td><td align="left" rowspan="1" colspan="1">3,301</td><td align="left" rowspan="1" colspan="1">941</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (g/100&#x000a0;kcal)</td><td align="left" rowspan="1" colspan="1">12.5</td><td align="left" rowspan="1" colspan="1">13.5</td><td align="left" rowspan="1" colspan="1">12.1</td><td align="left" rowspan="1" colspan="1">13.1</td><td align="left" rowspan="1" colspan="1">11.2</td><td align="left" rowspan="1" colspan="1">11.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (g/100&#x000a0;kcal)</td><td align="left" rowspan="1" colspan="1">5.5</td><td align="left" rowspan="1" colspan="1">4.6</td><td align="left" rowspan="1" colspan="1">5.2</td><td align="left" rowspan="1" colspan="1">4.8</td><td align="left" rowspan="1" colspan="1">4.0</td><td align="left" rowspan="1" colspan="1">4.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrate (g/100&#x000a0;kcal)</td><td align="left" rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1">3.6</td><td align="left" rowspan="1" colspan="1">3.6</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="left" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1">7.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium (mg/100&#x000a0;kcal)</td><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">85</td></tr><tr><td align="left" rowspan="1" colspan="1">EPA+DHA (mg/100 kcal)</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">80</td><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">111</td></tr><tr><td align="left" rowspan="1" colspan="1">Daidzein (&#x003bc;g/g)<xref ref-type="fn" rid="jvim12352-note-0002">+</xref>
</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">18&#x000a0;&#x000b1;&#x000a0;4</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">10&#x000a0;&#x000b1;&#x000a0;1</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td></tr><tr><td align="left" rowspan="1" colspan="1">Genistein (&#x003bc;g/g)<xref ref-type="fn" rid="jvim12352-note-0002">+</xref>
</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">19&#x000a0;&#x000b1;&#x000a0;5</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">15&#x000a0;&#x000b1;&#x000a0;1</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td><td align="left" rowspan="1" colspan="1">0&#x000a0;&#x000b1;&#x000a0;0</td></tr><tr><td align="left" rowspan="5" colspan="1">Main ingredients (in order by weight)</td><td align="left" rowspan="1" colspan="1">Turkey</td><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Chicken BPM</td><td align="left" rowspan="1" colspan="1">Pork by&#x02010;products</td><td align="left" rowspan="1" colspan="1">Corn</td><td align="left" rowspan="1" colspan="1">Pork by&#x02010;product</td></tr><tr><td align="left" rowspan="1" colspan="1">Chicken meal</td><td align="left" rowspan="1" colspan="1">Meat by&#x02010;products</td><td align="left" rowspan="1" colspan="1">Corn gluten meal</td><td align="left" rowspan="1" colspan="1">Pork liver</td><td align="left" rowspan="1" colspan="1">Poultry BPM</td><td align="left" rowspan="1" colspan="1">Water</td></tr><tr><td align="left" rowspan="1" colspan="1">Chicken</td><td align="left" rowspan="1" colspan="1">Chicken</td><td align="left" rowspan="1" colspan="1">Pork fat</td><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Corn gluten meal</td><td align="left" rowspan="1" colspan="1">Pork liver</td></tr><tr><td align="left" rowspan="1" colspan="1">Herring meal</td><td align="left" rowspan="1" colspan="1">Wheat gluten</td><td align="left" rowspan="1" colspan="1">Pork protein isolate</td><td align="left" rowspan="1" colspan="1">Corn starch</td><td align="left" rowspan="1" colspan="1">Animal liver flavor</td><td align="left" rowspan="1" colspan="1">Fish</td></tr><tr><td align="left" rowspan="1" colspan="1">Chicken fat</td><td align="left" rowspan="1" colspan="1">Corn starch</td><td align="left" rowspan="1" colspan="1">Powdered cellulose</td><td align="left" rowspan="1" colspan="1">Cellulose</td><td align="left" rowspan="1" colspan="1">Animal fat</td><td align="left" rowspan="1" colspan="1">Rice</td></tr></tbody></table><table-wrap-foot><fn id="jvim12352-note-0002"><p>ME, metabolizable energy; BPM, by&#x02010;product meal; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid *as fed, <sup>+</sup>dry matter</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>At the end of the 6&#x02010;month period, cats were re&#x02010;evaluated while still eating the assigned study diet. The same cardiologist evaluated each cat (except in 2 cases in which this was not logistically possible). All baseline laboratory, blood pressure, and echocardiographic measurements were repeated at this second visit.</p><p>The 2 primary endpoints for the study were LVWd and IVSd. Secondary endpoints were left atrial dimension and NT&#x02010;proBNP. However, as a preliminary study, multiple other clinical, echocardiographic, and laboratory variables were evaluated. No interim analysis or stopping criteria were established before beginning the study. Data distributions were assessed with the Kolmogorov&#x02010;Smirnov test. As many of the data were not normally distributed, all data are presented as median (range) and nonparametric tests were used. Baseline data among the 3 diet groups were compared by Kruskal&#x02010;Wallis tests. A comparison of baseline and follow&#x02010;up variables within each group was made using Wilcoxon signed ranks tests. Categorical data were compared with chi&#x02010;square tests. Because this was a pilot study, <italic>P</italic> values were not adjusted for multiple comparisons. However, to ensure that results were consistent and biologically plausible, interpretation of the statistical analyses was considered in similar categories (eg, echocardiographic measures of left ventricular hypertrophy, liver enzymes) to help determine whether the results were likely to be spurious because approximately 40 variables were evaluated). Data were analyzed with both the intention&#x02010;to&#x02010;treat principle, which included all 30 cats randomized to intervention and for only the 29 cats that completed the study. Because results were similar between the intention&#x02010;to&#x02010;treat and per protocol analyses, only the results for the 29 cats completing the study will be presented. Statistical significance was set at <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>.05. All statistical analyses were performed with commercially available software.<xref ref-type="fn" rid="jvim12352-note-0011">11</xref>, <xref ref-type="fn" rid="jvim12352-note-0012">12</xref>
</p></sec><sec id="jvim12352-sec-0009"><title>Results</title><p>Between August 2009 and August 2012, 39 cats were screened for enrollment (Fig&#x000a0;<xref rid="jvim12352-fig-0001" ref-type="fig">1</xref>). Nine cats were excluded for reasons shown in Figure&#x000a0;<xref rid="jvim12352-fig-0001" ref-type="fig">1</xref>, and 30 cats were randomized to 1 of 3 groups. All 30 cats received the allocated intervention. Twenty&#x02010;nine cats completed the 6&#x02010;month study. One cat from Group C died 17&#x000a0;days after beginning the study because of CHF. This cat had been diagnosed with HCM and started receiving atenolol 6&#x000a0;months before enrollment. Subsequent data will be presented only for the 29 cats that completed the study.</p><fig fig-type="Figure" xml:lang="en" id="jvim12352-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Consolidated Standards of Reporting Trials (<styled-content style="fixed-case">CONSORT</styled-content>) flow diagram detailing the number of cats that were assessed for eligibility, randomized, allocated, and that completed a 6&#x02010;month dietary intervention.<xref rid="jvim12352-bib-0022" ref-type="ref">22</xref>
</p></caption><graphic id="nlm-graphic-1" xlink:href="JVIM-28-0847-g001"/></fig><p>There were no significant differences among the 3 diet groups at baseline in signalment (Table&#x000a0;<xref rid="jvim12352-tbl-0002" ref-type="table-wrap">2</xref>), clinical characteristics (Table&#x000a0;<xref rid="jvim12352-tbl-0002" ref-type="table-wrap">2</xref>), echocardiographic measurements (Table&#x000a0;<xref rid="jvim12352-tbl-0003" ref-type="table-wrap">3</xref>), or biochemical variables (Table&#x000a0;<xref rid="jvim12352-tbl-0004" ref-type="table-wrap">4</xref>). The median age across all groups was 3.9, but ranged from 1.1 to 16.6&#x000a0;years. Most cats (86%) were male and all cats were neutered. All cats had been stable on any medications for at least 8&#x000a0;weeks. Medications included atenolol (n&#x000a0;=&#x000a0;14; Group A [n&#x000a0;=&#x000a0;6], Group B [n&#x000a0;=&#x000a0;4]; Group C [n&#x000a0;=&#x000a0;4]), clopidogrel (n&#x000a0;=&#x000a0;4; Group A [n&#x000a0;=&#x000a0;2], Group B [n&#x000a0;=&#x000a0;1], Group C [n&#x000a0;=&#x000a0;1]), and enalapril (n&#x000a0;=&#x000a0;3; n&#x000a0;=&#x000a0;1 in each Group). Sixteen of the 29 cats were receiving at least one of these medications, but the percentages of cats receiving at least 1 medication among the 3 groups was not significantly different (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.788). Medications did not change in any cat over the course of the 6&#x02010;month study.</p><table-wrap id="jvim12352-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Baseline demographic characteristics of 29 cats with asymptomatic hypertrophic cardiomyopathy that completed a randomized study assessing 3 dietary approaches (Group A, Group B, or Group C). Baseline data for Group C represent only the 9 cats that completed the 6&#x02010;month study. Data are presented as median (range).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Variable</th><th align="left" valign="top" rowspan="1" colspan="1">Group A</th><th align="left" valign="top" rowspan="1" colspan="1">Group B</th><th align="left" valign="top" rowspan="1" colspan="1">Group C</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">n</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1">4.3 (1.1&#x02013;10.4)</td><td align="left" rowspan="1" colspan="1">3.9 (1.1&#x02013;16.6)</td><td align="left" rowspan="1" colspan="1">4.0 (1.3&#x02013;8.9)</td><td align="left" rowspan="1" colspan="1">.808</td></tr><tr><td align="left" colspan="5" rowspan="1">Sex</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Castrated male</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="2" colspan="1">.779</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Spayed female</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" colspan="5" rowspan="1">Breed</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">DSH/DLH</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="5" colspan="1">.186</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Persian</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peterbald</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ragdoll</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Siamese</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="left" rowspan="1" colspan="1">4.6 (3.5&#x02013;6.8)</td><td align="left" rowspan="1" colspan="1">4.5 (4.1&#x02013;7.2)</td><td align="left" rowspan="1" colspan="1">4.9 (4.1&#x02013;6.1)</td><td align="left" rowspan="1" colspan="1">.773</td></tr><tr><td align="left" rowspan="1" colspan="1">Body condition score (1&#x02013;9)</td><td align="left" rowspan="1" colspan="1">5 (5&#x02013;7)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;9)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;8)</td><td align="left" rowspan="1" colspan="1">.512</td></tr><tr><td align="left" colspan="5" rowspan="1">Medications</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Atenolol</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">.645</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Enalapril</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.996</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Clopidogrel</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">.779</td></tr></tbody></table><table-wrap-foot><fn id="jvim12352-note-0003"><p>DSH/DLH, domestic shorthair/domestic longhair.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="jvim12352-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Blood pressure and echocardiographic measurements for 29 cats with asymptomatic hypertrophic cardiomyopathy that completed a randomized study assessing 3 dietary approaches (Group A, Group B, or Group C). Baseline data for Group C represent only the 9 cats that completed the 6&#x02010;month study. Data for each of the 3 groups are shown for baseline (at the time of starting the study) and at the 6&#x02010;month recheck visit. Data are presented as median (range). There were no significant differences among the 3 diet groups at baseline.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1">Variable</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group A</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group B</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group C</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BP (mmHg)</td><td align="left" rowspan="1" colspan="1">140 (103&#x02013;165)</td><td align="left" rowspan="1" colspan="1">135 (105&#x02013;172)</td><td align="left" rowspan="1" colspan="1">138 (118&#x02013;163)</td><td align="left" rowspan="1" colspan="1">145 (115&#x02013;158)</td><td align="left" rowspan="1" colspan="1">133 (101&#x02013;175)</td><td align="left" rowspan="1" colspan="1">140 (102&#x02013;175)</td></tr><tr><td align="left" colspan="7" rowspan="1">M&#x02010;Mode (in cm)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">IVSd</td><td align="left" rowspan="1" colspan="1">0.65 (0.53&#x02013;0.71)</td><td align="left" rowspan="1" colspan="1">0.60 (0.47&#x02013;0.82)</td><td align="left" rowspan="1" colspan="1">0.67 (0.51&#x02013;0.74)</td><td align="left" rowspan="1" colspan="1">0.74 (0.42&#x02013;0.90)</td><td align="left" rowspan="1" colspan="1">0.68 (0.64&#x02013;0.84)</td><td align="left" rowspan="1" colspan="1">0.69 (0.49&#x02013;0.75)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LVIDd</td><td align="left" rowspan="1" colspan="1">1.38 (1.28&#x02013;1.92)</td><td align="left" rowspan="1" colspan="1">1.49 (1.18&#x02013;1.94)</td><td align="left" rowspan="1" colspan="1">1.44 (1.26&#x02013;1.66)</td><td align="left" rowspan="1" colspan="1">1.38 (1.23&#x02013;1.65)</td><td align="left" rowspan="1" colspan="1">1.38 (1.23&#x02013;1.65)</td><td align="left" rowspan="1" colspan="1">1.43 (1.29&#x02013;1.61)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LVWd</td><td align="left" rowspan="1" colspan="1">0.69 (0.56&#x02013;0.98)</td><td align="left" rowspan="1" colspan="1">0.69 (0.50&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">0.69 (0.50&#x02013;0.94)</td><td align="left" rowspan="1" colspan="1">0.73 (0.48&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">0.71 (0.51&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">0.62 (0.47&#x02013;0.92)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">IVSs</td><td align="left" rowspan="1" colspan="1">0.87 (0.74&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">0.92 (0.63&#x02013;1.03)</td><td align="left" rowspan="1" colspan="1">0.90 (0.66&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">0.95 (0.54&#x02013;1.13)</td><td align="left" rowspan="1" colspan="1">0.89 (0.85&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">0.87 (0.75&#x02013;1.00)<xref ref-type="fn" rid="jvim12352-note-0004">a</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LVIDs</td><td align="left" rowspan="1" colspan="1">0.64 (0.30&#x02013;0.96)</td><td align="left" rowspan="1" colspan="1">0.68 (0.37&#x02013;0.98)</td><td align="left" rowspan="1" colspan="1">0.65 (0.45&#x02013;1.00)</td><td align="left" rowspan="1" colspan="1">0.69 (0.39&#x02013;0.93)</td><td align="left" rowspan="1" colspan="1">0.67 (0.41&#x02013;0.89)</td><td align="left" rowspan="1" colspan="1">0.66 (0.47&#x02013;0.88)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LVWs</td><td align="left" rowspan="1" colspan="1">1.00 (0.89&#x02013;1.30)</td><td align="left" rowspan="1" colspan="1">0.96 (0.83&#x02013;1.56)</td><td align="left" rowspan="1" colspan="1">0.92 (0.85&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">1.00 (0.73&#x02013;1.17)</td><td align="left" rowspan="1" colspan="1">0.98 (0.78&#x02013;1.27)</td><td align="left" rowspan="1" colspan="1">0.88 (0.74&#x02013;1.13)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LA</td><td align="left" rowspan="1" colspan="1">1.40 (1.15&#x02013;1.96)</td><td align="left" rowspan="1" colspan="1">1.55 (1.05&#x02013;2.42)</td><td align="left" rowspan="1" colspan="1">1.43 (1.24&#x02013;2.10)</td><td align="left" rowspan="1" colspan="1">1.39 (1.31&#x02013;2.52)</td><td align="left" rowspan="1" colspan="1">1.51 (1.18&#x02013;1.61)</td><td align="left" rowspan="1" colspan="1">1.39 (1.10&#x02013;1.65)<xref ref-type="fn" rid="jvim12352-note-0004">a</xref>
</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aorta</td><td align="left" rowspan="1" colspan="1">1.03 (0.88&#x02013;1.24)</td><td align="left" rowspan="1" colspan="1">1.04 (0.86&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1">1.03 (0.87&#x02013;1.20)</td><td align="left" rowspan="1" colspan="1">1.10 (0.80&#x02013;1.35)</td><td align="left" rowspan="1" colspan="1">1.13 (0.91&#x02013;1.23)</td><td align="left" rowspan="1" colspan="1">1.08 (0.95&#x02013;1.24)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LA:Aorta</td><td align="left" rowspan="1" colspan="1">1.41 (0.94&#x02013;1.90)</td><td align="left" rowspan="1" colspan="1">1.62 (0.96&#x02013;2.03)</td><td align="left" rowspan="1" colspan="1">1.31 (1.21&#x02013;2.41)</td><td align="left" rowspan="1" colspan="1">1.29 (1.15&#x02013;3.15)</td><td align="left" rowspan="1" colspan="1">1.33 (1.17&#x02013;1.68)</td><td align="left" rowspan="1" colspan="1">1.22 (1.02&#x02013;1.70)<xref ref-type="fn" rid="jvim12352-note-0004">a</xref>
</td></tr><tr><td align="left" colspan="7" rowspan="1">2D (in cm)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">IVSd 2D</td><td align="left" rowspan="1" colspan="1">0.67 (0.51&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">0.68 (0.45&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">0.74 (0.51&#x02013;0.89)</td><td align="left" rowspan="1" colspan="1">0.80 (0.43&#x02013;0.96)</td><td align="left" rowspan="1" colspan="1">0.76 (0.70&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">0.72 (0.65&#x02013;0.90)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LVWd 2D</td><td align="left" rowspan="1" colspan="1">0.71 (0.50&#x02013;0.96)</td><td align="left" rowspan="1" colspan="1">0.68 (0.55&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">0.76 (0.56&#x02013;0.90)</td><td align="left" rowspan="1" colspan="1">0.68 (0.52&#x02013;1.07)</td><td align="left" rowspan="1" colspan="1">0.76 (0.59&#x02013;0.92)</td><td align="left" rowspan="1" colspan="1">0.63 (0.43&#x02013;1.05)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LA 2D</td><td align="left" rowspan="1" colspan="1">1.51 (1.21&#x02013;2.09)</td><td align="left" rowspan="1" colspan="1">1.54 (1.37&#x02013;2.31)</td><td align="left" rowspan="1" colspan="1">1.34 (1.03&#x02013;2.27)</td><td align="left" rowspan="1" colspan="1">1.43 (1.05&#x02013;2.51)</td><td align="left" rowspan="1" colspan="1">1.51 (1.23&#x02013;1.78)</td><td align="left" rowspan="1" colspan="1">1.51 (1.10&#x02013;1.63)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aorta 2D</td><td align="left" rowspan="1" colspan="1">0.98 (0.83&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">0.98 (0.79&#x02013;1.09)</td><td align="left" rowspan="1" colspan="1">1.02 (0.82&#x02013;1.26)</td><td align="left" rowspan="1" colspan="1">0.98 (0.73&#x02013;1.16)</td><td align="left" rowspan="1" colspan="1">1.03 (0.89&#x02013;1.10)</td><td align="left" rowspan="1" colspan="1">1.04 (0.85&#x02013;1.21)</td></tr><tr><td align="left" colspan="7" rowspan="1">Doppler</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">AoVEL (m/s)</td><td align="left" rowspan="1" colspan="1">1.30 (0.66&#x02013;3.27)</td><td align="left" rowspan="1" colspan="1">1.05 (0.85&#x02013;4.03)</td><td align="left" rowspan="1" colspan="1">2.05 (0.99&#x02013;4.54)</td><td align="left" rowspan="1" colspan="1">2.04 (0.84&#x02013;5.70)</td><td align="left" rowspan="1" colspan="1">1.26 (0.72&#x02013;4.06)</td><td align="left" rowspan="1" colspan="1">1.45 (0.982&#x02013;3.93)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">E (m/s)</td><td align="left" rowspan="1" colspan="1">0.65 (0.46&#x02013;0.87)</td><td align="left" rowspan="1" colspan="1">0.65 (0.53&#x02013;1.12)</td><td align="left" rowspan="1" colspan="1">0.57 (0.49&#x02013;0.82)</td><td align="left" rowspan="1" colspan="1">0.58 (0.05&#x02013;1.19)</td><td align="left" rowspan="1" colspan="1">0.61 (0.51&#x02013;0.84)</td><td align="left" rowspan="1" colspan="1">0.57 (0.48&#x02013;0.85)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">A (m/s)</td><td align="left" rowspan="1" colspan="1">0.84 (0.55&#x02013;1.11)</td><td align="left" rowspan="1" colspan="1">0.79 (0.45&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">0.78 (0.61&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">0.67 (0.04&#x02013;1.01)</td><td align="left" rowspan="1" colspan="1">0.77 (0.51&#x02013;1.05)</td><td align="left" rowspan="1" colspan="1">0.77 (0.46&#x02013;1.21)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">E:A</td><td align="left" rowspan="1" colspan="1">0.78 (0.59&#x02013;0.84)</td><td align="left" rowspan="1" colspan="1">0.80 (0.68&#x02013;2.49)</td><td align="left" rowspan="1" colspan="1">0.78 (0.68&#x02013;0.97)</td><td align="left" rowspan="1" colspan="1">0.84 (0.66&#x02013;13.75)</td><td align="left" rowspan="1" colspan="1">0.84 (0.63&#x02013;1.20)</td><td align="left" rowspan="1" colspan="1">0.81 (0.62&#x02013;1.17)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">E' LVW (m/s)</td><td align="left" rowspan="1" colspan="1">0.05 (0.03&#x02013;0.08)</td><td align="left" rowspan="1" colspan="1">0.04 (0.03&#x02013;0.11)</td><td align="left" rowspan="1" colspan="1">0.06 (0.03&#x02013;0.07)</td><td align="left" rowspan="1" colspan="1">0.06 (0.03&#x02013;0.12)</td><td align="left" rowspan="1" colspan="1">0.05 (0.02&#x02013;0.09)</td><td align="left" rowspan="1" colspan="1">0.05 (0.03&#x02013;0.10)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">A' LVW (m/s)</td><td align="left" rowspan="1" colspan="1">0.07 (0.03&#x02013;0.11)</td><td align="left" rowspan="1" colspan="1">0.05 (0.03&#x02013;0.09)</td><td align="left" rowspan="1" colspan="1">0.06 (0.04&#x02013;0.08)</td><td align="left" rowspan="1" colspan="1">0.05 (0.03&#x02013;0.17)</td><td align="left" rowspan="1" colspan="1">0.06 (0.03&#x02013;0.41)</td><td align="left" rowspan="1" colspan="1">0.05 (0.02&#x02013;0.11)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">E/E' LVW</td><td align="left" rowspan="1" colspan="1">13.25 (8.13&#x02013;23.33)</td><td align="left" rowspan="1" colspan="1">15.50 (5.64&#x02013;28.00)</td><td align="left" rowspan="1" colspan="1">10.80 (9.50&#x02013;17.33)</td><td align="left" rowspan="1" colspan="1">13.17 (7.33&#x02013;20.50)</td><td align="left" rowspan="1" colspan="1">11.60 (7.43&#x02013;25.50)</td><td align="left" rowspan="1" colspan="1">10.40 (6.86&#x02013;18.00)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">IVRT (ms)</td><td align="left" rowspan="1" colspan="1">64.24 (33.27&#x02013;86.26)</td><td align="left" rowspan="1" colspan="1">58.02 (34.38&#x02013;98.58)</td><td align="left" rowspan="1" colspan="1">63.88 (42.50&#x02013;107.80)</td><td align="left" rowspan="1" colspan="1">53.05 (42.51&#x02013;80.70)</td><td align="left" rowspan="1" colspan="1">55.50 (41.90&#x02013;81.30)</td><td align="left" rowspan="1" colspan="1">57.3 (41.40&#x02013;94.90)</td></tr></tbody></table><table-wrap-foot><fn id="jvim12352-note-0004"><label>a</label><p>
<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>.05 comparing within group between baseline and recheck evaluations.</p></fn><fn id="jvim12352-note-0005"><p>2D, 2&#x02010;dimensional; A, late diastolic velocity of mitral inflow; A', late diastolic myocardial velocity; AoVEL, aortic velocity; BP, blood pressure; E, early diastolic velocity of mitral inflow; E', early peak diastolic myocardial velocity; IRVT, isovolumic relaxation time; IVSd/s, interventricular septal thickness in diastole/systole; LA, left atrium; LVWd/s, left ventricular free wall thickness in diastole/systole; LVIDd/s, left ventricular internal dimension in diastole/systole.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="jvim12352-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Body weight, body condition score, and laboratory measurements for 29 cats with asymptomatic hypertrophic cardiomyopathy that completed a randomized study assessing 3 dietary approaches (Group A, Group B, or Group C). Baseline data for Group C represent only the 9 cats that completed the 6&#x02010;month study. Data for each of the 3 groups are shown for baseline (at the time of starting the study) and at the 6&#x02010;month recheck visit. Data are presented as median (range). There were no significant differences among the 3 diet groups at baseline.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="top" colspan="1">Variable</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group A</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group B</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Group C</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th><th align="left" valign="top" rowspan="1" colspan="1">Baseline</th><th align="left" valign="top" rowspan="1" colspan="1">Recheck</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Body weight (kg)</td><td align="left" rowspan="1" colspan="1">4.6 (3.5&#x02013;6.8)</td><td align="left" rowspan="1" colspan="1">4.8 (3.9&#x02013;6.9)</td><td align="left" rowspan="1" colspan="1">4.5 (4.1&#x02013;7.2)</td><td align="left" rowspan="1" colspan="1">4.6 (3.9&#x02013;8.1)</td><td align="left" rowspan="1" colspan="1">4.9 (4.1&#x02013;6.1)</td><td align="left" rowspan="1" colspan="1">4.6 (3.7&#x02013;5.9)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Body condition score (1&#x02013;9)</td><td align="left" rowspan="1" colspan="1">5 (5&#x02013;7)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;7)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;9)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;9)</td><td align="left" rowspan="1" colspan="1">6 (5&#x02013;8)</td><td align="left" rowspan="1" colspan="1">5 (4&#x02013;7)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">BUN (mg/dL)</td><td align="left" rowspan="1" colspan="1">26 (15&#x02013;36)</td><td align="left" rowspan="1" colspan="1">32 (23&#x02013;45)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">24 (18&#x02013;33)</td><td align="left" rowspan="1" colspan="1">28 (24&#x02013;43)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">27 (19&#x02013;32)</td><td align="left" rowspan="1" colspan="1">27 (22&#x02013;32)</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="left" rowspan="1" colspan="1">1.5 (0.9&#x02013;1.9)</td><td align="left" rowspan="1" colspan="1">1.6 (0.8&#x02013;1.9)</td><td align="left" rowspan="1" colspan="1">1.5 (1.2&#x02013;1.7)</td><td align="left" rowspan="1" colspan="1">1.3 (0.8&#x02013;1.7)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">1.3 (1.1&#x02013;1.9)</td><td align="left" rowspan="1" colspan="1">1.3 (1.0&#x02013;1.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphorus (mg/dL)</td><td align="left" rowspan="1" colspan="1">4.5 (2.5&#x02013;5.5)</td><td align="left" rowspan="1" colspan="1">4.5 (3.5&#x02013;5.2)</td><td align="left" rowspan="1" colspan="1">4.4 (3.1&#x02013;5.4)</td><td align="left" rowspan="1" colspan="1">4.3 (3.3&#x02013;4.8)</td><td align="left" rowspan="1" colspan="1">4.4 (3.3&#x02013;6.8)</td><td align="left" rowspan="1" colspan="1">3.8 (2.6&#x02013;5.5)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Albumin (g/dL)</td><td align="left" rowspan="1" colspan="1">3.8 (3.3&#x02013;4.2)</td><td align="left" rowspan="1" colspan="1">3.9 (3.3&#x02013;4.6)</td><td align="left" rowspan="1" colspan="1">3.8 (3.3&#x02013;4.4)</td><td align="left" rowspan="1" colspan="1">3.8 (3.5&#x02013;4.4)</td><td align="left" rowspan="1" colspan="1">3.7 (3.4&#x02013;3.9)</td><td align="left" rowspan="1" colspan="1">3.8 (3.4&#x02013;4.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">ALP (U/L)</td><td align="left" rowspan="1" colspan="1">29 (17&#x02013;56)</td><td align="left" rowspan="1" colspan="1">23 (13&#x02013;31)</td><td align="left" rowspan="1" colspan="1">27 (12&#x02013;46)</td><td align="left" rowspan="1" colspan="1">25 (13&#x02013;52)</td><td align="left" rowspan="1" colspan="1">22 (12&#x02013;41)</td><td align="left" rowspan="1" colspan="1">20 (10&#x02013;34)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (U/L)</td><td align="left" rowspan="1" colspan="1">53 (33&#x02013;219)</td><td align="left" rowspan="1" colspan="1">49 (36&#x02013;71)</td><td align="left" rowspan="1" colspan="1">52 (26&#x02013;81)</td><td align="left" rowspan="1" colspan="1">53 (30&#x02013;66)</td><td align="left" rowspan="1" colspan="1">49 (36&#x02013;67)</td><td align="left" rowspan="1" colspan="1">45 (29&#x02013;60)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">AST (U/L)</td><td align="left" rowspan="1" colspan="1">29 (16&#x02013;62)</td><td align="left" rowspan="1" colspan="1">27 (18&#x02013;55)</td><td align="left" rowspan="1" colspan="1">32 (23&#x02013;53)</td><td align="left" rowspan="1" colspan="1">29 (21&#x02013;46)</td><td align="left" rowspan="1" colspan="1">27 (15&#x02013;68)</td><td align="left" rowspan="1" colspan="1">22 (16&#x02013;39)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholesterol (mg/dL)</td><td align="left" rowspan="1" colspan="1">167 (84&#x02013;262)</td><td align="left" rowspan="1" colspan="1">205 (149&#x02013;259)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">173 (109&#x02013;281)</td><td align="left" rowspan="1" colspan="1">235 (161&#x02013;386)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">151 (105&#x02013;314)</td><td align="left" rowspan="1" colspan="1">168 (108&#x02013;289)</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="left" rowspan="1" colspan="1">40 (19&#x02013;112)</td><td align="left" rowspan="1" colspan="1">51 (26&#x02013;106)</td><td align="left" rowspan="1" colspan="1">45 (33&#x02013;117)</td><td align="left" rowspan="1" colspan="1">105 (40&#x02013;709)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">44 (27&#x02013;87)</td><td align="left" rowspan="1" colspan="1">40 (24&#x02013;88)</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose (mg/dL)</td><td align="left" rowspan="1" colspan="1">107 (83&#x02013;138)</td><td align="left" rowspan="1" colspan="1">104 (79&#x02013;214)</td><td align="left" rowspan="1" colspan="1">100 (72&#x02013;244)</td><td align="left" rowspan="1" colspan="1">94 (72&#x02013;186)</td><td align="left" rowspan="1" colspan="1">109 (67&#x02013;179)</td><td align="left" rowspan="1" colspan="1">110 (85&#x02013;173)</td></tr><tr><td align="left" rowspan="1" colspan="1">Insulin (pmol/L)</td><td align="left" rowspan="1" colspan="1">100 (62&#x02013;193)</td><td align="left" rowspan="1" colspan="1">75 (49&#x02013;162)</td><td align="left" rowspan="1" colspan="1">114 (64&#x02013;228)</td><td align="left" rowspan="1" colspan="1">145 (51&#x02013;214)</td><td align="left" rowspan="1" colspan="1">119 (54&#x02013;188)</td><td align="left" rowspan="1" colspan="1">106 (65&#x02013;145)</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA</td><td align="left" rowspan="1" colspan="1">4.27 (1.83&#x02013;9.12)</td><td align="left" rowspan="1" colspan="1">3.54 (1.90&#x02013;5.29)</td><td align="left" rowspan="1" colspan="1">4.26 (1.64&#x02013;19.76)</td><td align="left" rowspan="1" colspan="1">4.79 (1.33&#x02013;10.31)</td><td align="left" rowspan="1" colspan="1">6.50 (1.76&#x02013;8.27)</td><td align="left" rowspan="1" colspan="1">4.08 (1.96&#x02013;5.84)</td></tr><tr><td align="left" rowspan="1" colspan="1">NT&#x02010;proBNP (pmol/L)</td><td align="left" rowspan="1" colspan="1">535 (34&#x02013;1402)</td><td align="left" rowspan="1" colspan="1">431 (24&#x02013;1500)</td><td align="left" rowspan="1" colspan="1">600 (118&#x02013;1158)</td><td align="left" rowspan="1" colspan="1">393 (56&#x02013;1152)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">515 (24&#x02013;1500)</td><td align="left" rowspan="1" colspan="1">209 (24&#x02013;1500)</td></tr><tr><td align="left" rowspan="1" colspan="1">hs&#x02010;troponin I (ng/mL)</td><td align="left" rowspan="1" colspan="1">0.31 (0.20&#x02013;3.87)</td><td align="left" rowspan="1" colspan="1">0.42 (0.20&#x02013;1.18)</td><td align="left" rowspan="1" colspan="1">0.47 (0.20&#x02013;1.54)</td><td align="left" rowspan="1" colspan="1">0.20 (0.20&#x02013;1.12)<xref ref-type="fn" rid="jvim12352-note-0006">a</xref>
</td><td align="left" rowspan="1" colspan="1">0.38 (0.20&#x02013;0.95)</td><td align="left" rowspan="1" colspan="1">0.20 (0.20&#x02013;1.25)</td></tr></tbody></table><table-wrap-foot><fn id="jvim12352-note-0006"><label>a</label><p>
<italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>.05 comparing within group between baseline and recheck evaluations.</p></fn><fn id="jvim12352-note-0007"><p>ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; HOMA, homeostasis model assessment; NT&#x02010;proBNP, N&#x02010;terminal pro B&#x02010;type natriuretic peptide.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>At the time of enrollment, most cats ate all (n&#x000a0;=&#x000a0;13; 45%) or mostly (n&#x000a0;=&#x000a0;8; 28%) dry food, although other feeding practices included all canned (n&#x000a0;=&#x000a0;5; 17%), 50% canned and 50% dry (n&#x000a0;=&#x000a0;2; 7%), and mostly canned (n&#x000a0;=&#x000a0;1; 4%). The form of food was not significantly different among groups (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.158). Cats continued to eat the same forms of diet that they had eaten before starting the study (ie, if they ate all canned food before enrollment, they continued to eat all canned food during the 6&#x02010;month study), with the exception of 1 cat. This cat had a history of feline idiopathic cystitis and had been eating all dry food before study enrollment. Ten weeks after enrollment, the cat had an episode of dysuria. The cat was switched to eating mostly canned food and no further episodes of dysuria occurred for the duration of the study. The median dietary sodium for all 29 cats at the time of enrollment in the study (122&#x000a0;mg/100&#x000a0;kcal [range, 82&#x02013;321&#x000a0;mg/100&#x000a0;kcal]) decreased significantly after changing to the study diets (95&#x000a0;mg/100&#x000a0;kcal [range, 85&#x02013;100&#x000a0;mg/100&#x000a0;kcal]; <italic>P&#x000a0;</italic>&#x0003c;<italic>&#x000a0;</italic>.001). There were also significant within&#x02010;group decreases in dietary sodium in Diet Groups A (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.021) and B (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.012). However, for Diet Group C, the numerical decrease in dietary sodium was not statistically significant (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.066).</p><p>The primary endpoints for the study were IVSd and LVWd. Neither of these primary endpoints changed significantly in any of the 3 diet groups over the course of the study (Table&#x000a0;<xref rid="jvim12352-tbl-0003" ref-type="table-wrap">3</xref>; Fig <xref rid="jvim12352-fig-0003" ref-type="fig">3</xref>). One of the secondary endpoints, left atrial dimension, decreased significantly only in Group C (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.035; Fig&#x000a0;<xref rid="jvim12352-fig-0002" ref-type="fig">2</xref>), while the other secondary endpoint, NT&#x02010;proBNP, decreased significantly only in Group B (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.013; Table&#x000a0;<xref rid="jvim12352-tbl-0004" ref-type="table-wrap">4</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim12352-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Median change in left atrial (M&#x02010;mode; <bold>A</bold>) and left atrial 2D (2&#x02010;dimensional; <bold>B</bold>) measurements for each of the 3 diet groups from baseline to 6&#x02010;month recheck examination. Diet Group A (n&#x000a0;=&#x000a0;10); Diet Group B (n&#x000a0;=&#x000a0;10); Diet Group C (n&#x000a0;=&#x000a0;9). <italic>P</italic> values are for the within&#x02010;group change over the 6&#x02010;month study period. Only the change for the left atrial dimension for Diet Group C was statistically significant.</p></caption><graphic id="nlm-graphic-3" xlink:href="JVIM-28-0847-g002"/></fig><fig fig-type="Figure" xml:lang="en" id="jvim12352-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Median change in interventricular septal thickness in diastole (<styled-content style="fixed-case">IVS</styled-content>d; <bold>A</bold>) and systole (<styled-content style="fixed-case">IVS</styled-content>s; <bold>C</bold>) and left ventricular free wall in diastole (<styled-content style="fixed-case">LVW</styled-content>d; <bold>B</bold>) and systole (<styled-content style="fixed-case">LVW</styled-content>s; <bold>D</bold>) for each of the 3 diet groups from baseline to 6&#x02010;month recheck examination. Diet Group A (n&#x000a0;=&#x000a0;10); Diet Group B (n&#x000a0;=&#x000a0;10); Diet Group C (n&#x000a0;=&#x000a0;9). <italic>P</italic> values are for the within&#x02010;group change over the 6&#x02010;month study period. Only the change for <styled-content style="fixed-case">IVS</styled-content>s for Diet Group C was statistically significant.</p></caption><graphic id="nlm-graphic-5" xlink:href="JVIM-28-0847-g003"/></fig><p>In addition to the primary and secondary endpoints, a number of other variables were assessed in this pilot study. Over the course of the 6&#x02010;month study, body weight (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.021) and BCS (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.007) decreased significantly only in Group C (Table&#x000a0;<xref rid="jvim12352-tbl-0004" ref-type="table-wrap">4</xref>). Eight cats in Group C lost weight, while 6 cats in Group B and 2 cats in Group A lost weight (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.01). Group A had significant increases in BUN (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.008) and cholesterol (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.021). Group B had significant increases in BUN (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.008), cholesterol (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.007), and triglycerides (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.005), and significant decreases in NT&#x02010;proBNP (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.013), hs&#x02010;troponin I (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.043), and creatinine (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.018). Group C had significant decreases in phosphorus (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.025), alkaline phosphatase (ALP; <italic>P&#x000a0;</italic>= .034), alanine aminotransferase (ALT; <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.038), and aspartate aminotransferase (AST; <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.038).</p><p>Blood pressure did not change significantly in any group (Table&#x000a0;<xref rid="jvim12352-tbl-0003" ref-type="table-wrap">3</xref>). Over the 6&#x02010;month study period, in addition to the significant decrease in left atrial dimension, Group C had significant decreases in interventricular septal thickness in systole (IVSs; <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.038; Table&#x000a0;<xref rid="jvim12352-tbl-0003" ref-type="table-wrap">3</xref>; Fig&#x000a0;<xref rid="jvim12352-fig-0003" ref-type="fig">3</xref>) and the ratio of the left atrium to the aorta (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.011). In Group C, there were also numerical, but not statistically significant, decreases in IVSd (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.097; Fig&#x000a0;<xref rid="jvim12352-fig-0003" ref-type="fig">3</xref>), LVWd (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.066; Fig&#x000a0;<xref rid="jvim12352-fig-0003" ref-type="fig">3</xref>), left ventricular free wall in systole (LVWs; <italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.086; Fig&#x000a0;<xref rid="jvim12352-fig-0003" ref-type="fig">3</xref>), LVWd 2D (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.086; Fig&#x000a0;<xref rid="jvim12352-fig-0004" ref-type="fig">4</xref>), and IVSd 2D (<italic>P&#x000a0;</italic>=<italic>&#x000a0;</italic>.066; Fig&#x000a0;<xref rid="jvim12352-fig-0004" ref-type="fig">4</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jvim12352-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Median change in 2D (2&#x02010;dimensional) interventricular septal thickness in diastole (A) and 2D left ventricular free wall in diastole (B) for each of the 3 diet groups from baseline to 6&#x02010;month recheck examination. Diet Group A (n&#x000a0;=&#x000a0;10); Diet Group B (n&#x000a0;=&#x000a0;10); Diet Group C (n&#x000a0;=&#x000a0;9). <italic>P</italic> values are for the within&#x02010;group change over the 6&#x02010;month study period. None of the changes were statistically significant.</p></caption><graphic id="nlm-graphic-7" xlink:href="JVIM-28-0847-g004"/></fig><p>There were no significant differences in laboratory variables or echocardiographic measurements between cats eating all or mostly dry foods and cats eating all or mostly canned foods. There also were no significant differences in results when comparing cats that lost weight to cats that maintained or gained weight.</p></sec><sec id="jvim12352-sec-0010"><title>Discussion</title><p>In this small preliminary study, the 2 primary endpoints (IVSd and LVWd) did not change significantly. Left atrium (a secondary endpoint) decreased significantly over the course of the 6&#x02010;month study. Interventricular septal thickness in systole, which was not a primary or secondary endpoint, also decreased significantly. However, none of the other numerical decreases in echocardiographic measures of left ventricular hypertrophy (ie, IVSd, LVWd, LVWs, IVSd 2D, LVWd 2D) were statistically significant. Although these changes are intriguing, much additional research with larger sample sizes is required to determine the true effect of diet on echocardiographic variables.</p><p>The significant decrease in NT&#x02010;proBNP in Group B does not appear to be related to changes in cardiac morphology because Diet Group B did not have significant reductions in left ventricular hypertrophy. The change in NT&#x02010;proBNP in Group B also might be related to variability in NT&#x02010;proBNP measurements, which has been shown in dogs,<xref rid="jvim12352-bib-0014" ref-type="ref">14</xref> or to changes in dietary sodium intake.<xref rid="jvim12352-bib-0015" ref-type="ref">15</xref> Dietary sodium (on a mg/100&#x000a0;kcal basis) decreased significantly for all 29 cats as a group, and individually for Diet Groups A and B. The current study did not measure absolute food intake, which would have allowed for calculation of sodium intake on a mg/day basis and is a limitation, but the fact that the median sodium content of the diet decreased significantly suggests that cats were likely to also have a decrease in their total daily sodium intake. This emphasizes the importance of obtaining a complete diet history for cats with cardiac disease at every visit.<xref rid="jvim12352-bib-0007" ref-type="ref">7</xref> High&#x02010;sensitivity troponin I also decreased significantly only in Diet Group B, but possible relationships between diet and hs&#x02010;troponin I are not well documented.</p><p>Because some metabolic changes have been seen in previous studies of cats with HCM<xref rid="jvim12352-bib-0016" ref-type="ref">16</xref>, <xref rid="jvim12352-bib-0017" ref-type="ref">17</xref> and because the macronutrient properties of the test diets could result in biochemical changes, a number of additional variables were evaluated in this study. Groups A and B showed a significant increase in BUN, without a concomitant increase in creatinine. While an increased BUN:creatinine ratio can occur for a number of reasons (eg, GI bleeding, pre&#x02010; or postrenal azotemia, catabolism), the finding in the current study was most likely related to the relatively high protein content of these 2 diets (12.1&#x02013;13.5&#x000a0;g/100&#x000a0;kcal). Although the protein content of the diets used in Group C (11.2&#x02013;11.5&#x000a0;g/100&#x000a0;kcal) was slightly lower than the protein of the diets in Groups A and B, it is still well above the Association of American Feed Control Officials Cat Food Nutrient Profile minimum of 6.5&#x000a0;g/100&#x000a0;kcal for adult maintenance. The effect of changes in BUN or creatinine on myocardial hypertrophy or on the progression of HCM is unknown. Cholesterol (for Group A) and triglycerides (for Groups A and B) increased significantly during the 6&#x02010;month study, but did not change in Group C. This is probably related to the dietary fat content, which was lower in Group C, but also might be influenced by the fact that some of the cats in Group C lost weight over the course of study. Cholesterol and triglyceride concentrations were not significantly different in a study of Maine Coon cats with and without HCM,<xref rid="jvim12352-bib-0017" ref-type="ref">17</xref> so the effect of changes in cholesterol and triglycerides in HCM is unknown. It is unclear why ALP, ALT, AST activities all decreased significantly in Group C. This might be related to effects of lower dietary fat content,<xref rid="jvim12352-bib-0018" ref-type="ref">18</xref> weight loss,<xref rid="jvim12352-bib-0019" ref-type="ref">19</xref> or, for the ALT and AST (for which there are myocardial isoenzymes), reduced myocardial injury.<xref rid="jvim12352-bib-0020" ref-type="ref">20</xref>
</p><p>As a result of the dietary properties selected for the test diets used in the current study, the calorie density of the diets fed in Group C (particularly the dry option, the most commonly eaten form) was lower than in the diets fed in Groups A and B. Accordingly, the median body weight and body condition score in Group C decreased significantly, and 8 of the 9 cats in this group lost body weight. The goal of the study was to have all cats maintain body weight during the study, so owners were instructed to feed an amount to maintain current body weight for the duration of the study. Owners also were encouraged to weigh the cat during the study, especially if body weight appeared to be changing so that adjustment of food amounts could be made. Nonetheless, the lower calorie density (and insufficient frequency of weighing) probably resulted in weight loss in Group C. While statistical analysis did not show a difference in echocardiographic or biochemical variables between cats that lost weight and those that maintained or gained weight, it cannot be excluded that the weight loss itself, rather than the diet, resulted in changes. One case report showed significant echocardiographic improvements in a 17&#x02010;year&#x02010;old boy with HCM after weight loss (from 137.9 to 88.9&#x000a0;kg).<xref rid="jvim12352-bib-0021" ref-type="ref">21</xref> Research on possible direct effects of weight loss on echocardiographic and laboratory parameters is warranted.</p><p>In addition to the important limitation of weight loss in Group C, this study had a number of other limitations that must be addressed. As previously mentioned, commercially available foods with specific properties were selected, rather than formulating specific experimental diets for this pilot study. While the foods selected had the specific properties the investigators desired to test, some of the carbohydrate, fat, and ingredient differences were not as distinct as could be achieved with experimental diets, and nutrients other than the ones being tested also were different (eg, vitamins, minerals). In addition, while canned and dry versions within each group were selected to be as similar as possible, there were some differences, both in profile and in ingredients, between the 2 forms of food. While most cats (69%) ate all or mostly dry food, these differences between the canned and dry forms inevitably resulted in additional variation in nutrient intake within each group.</p><p>Another limitation is the small sample size of this study. Because previous studies were not available to confirm the investigators' hypothesis that diet could modify these variables, the study was designed to confirm or refute this hypothesis before embarking on a larger, more expensive study. Therefore, statistical power was insufficient to identify statistical differences for many of the endpoints, if there was indeed a difference. Another issue that might have affected results is the duration of the treatment (ie, 6&#x000a0;months). Longer studies are probably needed to see full effects of dietary modification on echocardiographic variables. Given the changes that were seen in the current study, both those that were significant and the other consistent trends, the investigators believe that further studies based on what has been learned from this study are warranted.</p><p>Other limitations of the study include medications and disease severity. Cats were not prohibited from receiving medications in the current study as long as they had been receiving the medication for at least 8&#x000a0;weeks and, in fact, 55% of cats in the study were receiving at least 1 cardiac medication. Although there were no differences in medications among the 3 groups, there is potential for effects of medication on echocardiographic variables. In addition, while all cats were categorized as ISACHC Stage 1b at the beginning of the study, the severity of disease varied (eg, degree of left ventricular hypertrophy, left atrial enlargement, left ventricular outflow tract obstruction). Future studies should control for both of these factors to address their potential effects on endpoints.</p><p>Finally, it must be acknowledged that changes in echocardiographic parameters (ie, reduction in left atrial size or degree of left ventricular hypertrophy) do not necessarily equate to a better outcome, slower progression, or longer survival, and additional studies are required to prove that even if dietary modification can result in improved echocardiographic changes, that this translates to improved clinical outcome.</p><p>Nonetheless, the results of this study suggest that diet might modify some biochemical and echocardiographic variables in cats with HCM without clinical signs. Additional studies are needed to determine the effects of nutrition on phenotypic expression of cardiac disease.</p></sec></body><back><ack id="jvim12352-sec-0011"><title>Acknowledgments</title><p>The authors thank Kristen Antoon for her invaluable assistance in data collection for this study, Katie Cyr and IDEXX Laboratories for support of shipping and analysis of NT&#x02010;proBNP samples, and Dr Scott Jaques for the high&#x02010;sensitivity troponin I analyses. This study was supported by the Barkley Fund.</p><p>
<italic>Conflict of Interest Declaration:</italic> Dr Freeman reports grants from Boehringer Ingelheim, grants and personal fees from Nestl&#x000e9; Purina PetCare, personal fees from The Nutro Company, personal fees from P&#x00026;G Petcare, and grants and personal fees from Royal Canin outside the submitted work; Dr Rush reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from IDEXX Laboratories, grants and personal fees from Nestl&#x000e9; Purina PetCare, and grants and personal fees from Royal Canin outside the submitted work; Dr Bulmer reports personal fees from Boehringer Ingelheim outside the submitted work.</p></ack><fn-group id="jvim12352-ntgp-0006"><title>Footnotes</title><fn id="jvim12352-note-1001"><label>1</label><p>GE Vivid 7 Dimension, General Electric Healthcare, Milwaukee, WI</p></fn><fn id="jvim12352-note-1002"><label>2</label><p>Human Insulin Specific Immunoassay, Millipore, St Charles, MO</p></fn><fn id="jvim12352-note-1003"><label>3</label><p>Immulite 2000<sup>&#x000ae;</sup> Immunoassay System, Siemens Medical Solutions, Inc., Malvern, PA</p></fn><fn id="jvim12352-note-1004"><label>4</label><p>Feline CardioPet NT&#x02010;proBNP, IDEXX Laboratories, Westbrook, ME</p></fn><fn id="jvim12352-note-1005"><label>5</label><p>EVO<sup>&#x000ae;</sup> Turkey &#x00026; Chicken Formula Dry Cat &#x00026; Kitten Food, Natura Pet Products, Fremont, NE</p></fn><fn id="jvim12352-note-1006"><label>6</label><p>Pro Plan<sup>&#x000ae;</sup> Urinary Tract Health Formula Chicken Entree &#x02010; In Gravy, Nestl&#x000e9; Purina PetCare, St Louis, MO</p></fn><fn id="jvim12352-note-1007"><label>7</label><p>Prescription Diet<sup>&#x000ae;</sup> m/d<sup>&#x000ae;</sup> Feline dry, Hill's Pet Nutrition, Topeka, KS</p></fn><fn id="jvim12352-note-0008"><label>8</label><p>Prescription Diet<sup>&#x000ae;</sup> m/d<sup>&#x000ae;</sup> Feline canned, Hill's Pet Nutrition</p></fn><fn id="jvim12352-note-0009"><label>9</label><p>Purina Veterinary Diets<sup>&#x000ae;</sup> DH Dental Health Formula, Nestle Purina PetCare</p></fn><fn id="jvim12352-note-0010"><label>10</label><p>Prescription Diet<sup>&#x000ae;</sup> c/d<sup>&#x000ae;</sup> Multicare with Seafood Feline canned, Hill's Pet Nutrition</p></fn><fn id="jvim12352-note-0011"><label>11</label><p>SPSS 21.0, SPSS, Chicago, IL</p></fn><fn id="jvim12352-note-0012"><label>12</label><p>Systat 13.0, Systat Software, Chicago, IL</p></fn></fn-group><ref-list content-type="cited-references" id="jvim12352-bibl-0001"><title>References</title><ref id="jvim12352-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jvim12352-cit-0001">
<string-name>
<surname>Stauffer</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Konhilas</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Luczak</surname>
<given-names>ED</given-names>
</string-name>, <string-name>
<surname>Leinwand</surname>
<given-names>LA</given-names>
</string-name>. <article-title>Soy diet worsens heart disease in mice</article-title>. <source>J Clin Invest</source>
<year>2006</year>;<volume>116</volume>:<fpage>209</fpage>&#x02013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">16395406</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jvim12352-cit-0002">
<string-name>
<surname>Rees</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Gioscia&#x02010;Ryan</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>McCune</surname>
<given-names>SA</given-names>
</string-name>, et&#x000a0;al. <article-title>The AIN&#x02010;76A defined rodent diet accelerates the development of heart failure in SHHF rats: A cautionary note on its use in cardiac studies</article-title>. <source>J Anim Physiol Anim Nutr</source>
<year>2014</year>;<volume>98</volume>:<fpage>56</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="jvim12352-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jvim12352-cit-0003">
<string-name>
<surname>Olivotto</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Maron</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Tomberli</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy</article-title>. <source>J Am Coll Cardiol</source>
<year>2013</year>;<volume>62</volume>:<fpage>449</fpage>&#x02013;<lpage>457</lpage>.<pub-id pub-id-type="pmid">23643593</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jvim12352-cit-0004">
<string-name>
<surname>Ommen</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Lopez&#x02010;Jimenez</surname>
<given-names>F</given-names>
</string-name>. <article-title>Obesity and hypertrophic cardiomyopathy: Chickens, eggs, and causality: Clinical skills remain the key to caring for patients</article-title>. <source>J Am Coll Cardiol</source>
<year>2013</year>;<volume>62</volume>:<fpage>458</fpage>&#x02013;<lpage>459</lpage>.<pub-id pub-id-type="pmid">23643594</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0005"><label>5</label><mixed-citation publication-type="book" id="jvim12352-cit-0005">
<collab collab-type="authors">International Small Animal Cardiac Health Council</collab>
. <source>Recommendations for the Diagnosis of Heart Disease and the Treatment of Heart Failure in Small Animals</source>. <publisher-name>International Small Animal Cardiac Health Council</publisher-name>; <year>2004</year>:<fpage>5</fpage>.</mixed-citation></ref><ref id="jvim12352-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jvim12352-cit-0006">
<string-name>
<surname>Laflamme</surname>
<given-names>DP</given-names>
</string-name>. <article-title>Development and validation of a body condition score system for cats</article-title>. <source>Feline Pract</source>
<year>1997</year>;<volume>25</volume>:<fpage>13</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="jvim12352-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jvim12352-cit-0007">
<collab collab-type="authors">WSAVA Nutritional Assessment Guidelines Taskforce</collab>
: <string-name>
<surname>Freeman</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Cave</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>McKay</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Nutritional Assessment Guidelines</article-title>. <source>J Small Anim Pract</source>
<year>2011</year>;<volume>52</volume>:<fpage>385</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">21649660</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jvim12352-cit-0008">
<string-name>
<surname>Thomas</surname>
<given-names>WP</given-names>
</string-name>, <string-name>
<surname>Gaber</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Jacobs</surname>
<given-names>GJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Recommendations for standards in transthoracic two&#x02010;dimensional echocardiography in the dog and cat</article-title>. <source>J Vet Intern Med</source>
<year>1993</year>;<volume>7</volume>:<fpage>247</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">8246215</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jvim12352-cit-0009">
<string-name>
<surname>Chetboul</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Concordet</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pouchelon</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Effects of inter&#x02010; and intra&#x02010;observer variability on echocardiographic measurements in awake cats</article-title>. <source>J Vet Med A Physiol Pathol Clin Med</source>
<year>2005</year>;<volume>50</volume>:<fpage>326</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">12887627</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jvim12352-cit-0010">
<string-name>
<surname>Rishniw</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Erb</surname>
<given-names>HN</given-names>
</string-name>. <article-title>Evaluation of four 2&#x02010;dimensional echocardiographic methods of assessing left atrial size in dogs</article-title>. <source>J Vet Intern Med</source>
<year>2000</year>;<volume>14</volume>:<fpage>429</fpage>&#x02013;<lpage>435</lpage>.<pub-id pub-id-type="pmid">10935894</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jvim12352-cit-0011">
<string-name>
<surname>Fox</surname>
<given-names>PR</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Maron</surname>
<given-names>BJ</given-names>
</string-name>. <article-title>Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease</article-title>. <source>Circulation</source>
<year>1995</year>;<volume>92</volume>:<fpage>2645</fpage>&#x02013;<lpage>2651</lpage>.<pub-id pub-id-type="pmid">7586368</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jvim12352-cit-0012">
<string-name>
<surname>Appleton</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Rand</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Sunvold</surname>
<given-names>GD</given-names>
</string-name>. <article-title>Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats</article-title>. <source>J Feline Med Surg</source>
<year>2005</year>;<volume>7</volume>:<fpage>183</fpage>&#x02013;<lpage>193</lpage>.<pub-id pub-id-type="pmid">15922225</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jvim12352-cit-0013">
<string-name>
<surname>Court</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Identification and concentration of soy isoflavones in commercial cat foods</article-title>. <source>Am J Vet Res</source>
<year>2002</year>;<volume>63</volume>:<fpage>181</fpage>&#x02013;<lpage>185</lpage>.<pub-id pub-id-type="pmid">11843115</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jvim12352-cit-0014">
<string-name>
<surname>Kellihan</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Oyama</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Reynolds</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Stepien</surname>, <given-names>RL</given-names>
</string-name>. <article-title>Weekly variability of plasma and serum NT&#x02010;proBNP measurements in normal dogs</article-title>. <source>J Vet Cardiol</source>
<year>2009</year>;<volume>11</volume>(<issue>Suppl 1</issue>):<fpage>S93</fpage>&#x02013;<lpage>S97</lpage>.<pub-id pub-id-type="pmid">19395335</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jvim12352-cit-0015">
<string-name>
<surname>Sadanaga</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ando</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hirota</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>B&#x02010;type natriuretic peptide levels are decreased by reducing dietary salt intake in patients with compensated heart failure with preserved ejection fraction</article-title>. <source>Intern Med J</source>
<year>2013</year>;<volume>43</volume>:<fpage>663</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="pmid">23279137</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jvim12352-cit-0016">
<string-name>
<surname>Yang</surname>
<given-names>VK</given-names>
</string-name>, <string-name>
<surname>Freeman</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Rush</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Comparisons of morphometric measurements and serum insulin&#x02010;like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy</article-title>. <source>Am J Vet Res</source>
<year>2008</year>;<volume>69</volume>:<fpage>1061</fpage>&#x02013;<lpage>1066</lpage>.<pub-id pub-id-type="pmid">18672971</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jvim12352-cit-0017">
<string-name>
<surname>Freeman</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Rush</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Meurs</surname>
<given-names>KM</given-names>
</string-name>, et&#x000a0;al. <article-title>Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy</article-title>. <source>J Feline Med Surg</source>
<year>2013</year>;<volume>15</volume>:<fpage>74</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">23001953</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jvim12352-cit-0018">
<string-name>
<surname>de Meijer</surname>
<given-names>VE</given-names>
</string-name>, <string-name>
<surname>Le</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Meisel</surname>
<given-names>JA</given-names>
</string-name>, et&#x000a0;al. <article-title>Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model</article-title>. <source>Metabolism</source>
<year>2010</year>;<volume>59</volume>:<fpage>1092</fpage>&#x02013;<lpage>1105</lpage>.<pub-id pub-id-type="pmid">20060143</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jvim12352-cit-0019">
<string-name>
<surname>Rodriguez&#x02010;Hernandez</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cervantes&#x02010;Huerta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rodriguez&#x02010;Moran</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Guerrero&#x02010;Romero</surname>, <given-names>F</given-names>
</string-name>. <article-title>Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet</article-title>. <source>Ann Hepatol</source>
<year>2011</year>;<volume>10</volume>:<fpage>486</fpage>&#x02013;<lpage>492</lpage>.<pub-id pub-id-type="pmid">21911890</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jvim12352-cit-0020">
<string-name>
<surname>Lofthus</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>PW</given-names>
</string-name>, et&#x000a0;al. <article-title>Pattern of liver enzyme elevations in acute ST&#x02010;elevation myocardial infarction</article-title>. <source>Coron Artery Dis</source>
<year>2012</year>;<volume>23</volume>:<fpage>22</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">22113063</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jvim12352-cit-0021">
<string-name>
<surname>Uwaifo</surname>
<given-names>GI</given-names>
</string-name>, <string-name>
<surname>Fallon</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Calis</surname>
<given-names>KA</given-names>
</string-name>, et&#x000a0;al. <article-title>Improvement in hypertrophic cardiomyopathy after significant weight loss: Case report</article-title>. <source>South Med J</source>
<year>2003</year>;<volume>96</volume>:<fpage>626</fpage>&#x02013;<lpage>631</lpage>.<pub-id pub-id-type="pmid">12938797</pub-id></mixed-citation></ref><ref id="jvim12352-bib-0022"><label>22</label><mixed-citation publication-type="miscellaneous" id="jvim12352-cit-0022">
<collab collab-type="authors">CONSORT Group</collab>
. <article-title>Consolidated standards of reporting trials</article-title>. <year>2010</year> Available at: <ext-link ext-link-type="uri" xlink:href="http://www.consort-statement.org">http://www.consort-statement.org</ext-link>. Accessed August 18, 2013.</mixed-citation></ref></ref-list></back></article>